www.fdanews.com/articles/62496-biopure-avoids-sec-fine
BIOPURE AVOIDS SEC FINE
September 13, 2006
Biopure Corp. won't have to pay penalties to settle allegations it touted the prospects for a synthetic blood product without disclosing that drug regulators had concerns about the product's safety, the Securities and Exchange Commission said Tuesday.
Yahoo
Finance